https://cluster-site.onrender.com/tags/novartis/ Recent content in Novartis on Tenu Tech Brief Hugo -- 0.146.0 en-us Tue, 24 Feb 2026 06:04:26 +0000 https://cluster-site.onrender.com/posts/novartis-commits-100m-to-startup-with-tech-that-brings-peptides-to-undruggable-targets/ Thu, 19 Feb 2026 20:47:39 +0000 https://cluster-site.onrender.com/posts/novartis-commits-100m-to-startup-with-tech-that-brings-peptides-to-undruggable-targets/ • Novartis’s alliance with Unnatural Products is pursuing next-generation peptide drugs for cardiovascular disease. • The startup already has drug R&D alliances with BridgeBio Phar https://cluster-site.onrender.com/posts/who-renews-commitment-to-a-leprosy-free-world-spotlighting-partnership-and-progress-ahead-of-world-leprosy-day/ Wed, 21 Jan 2026 17:14:46 +0000 https://cluster-site.onrender.com/posts/who-renews-commitment-to-a-leprosy-free-world-spotlighting-partnership-and-progress-ahead-of-world-leprosy-day/ • WHO reaffirms leprosy elimination goal, highlighting partnership with Novartis. • 172,717 new cases reported worldwide in 2024, yet 55 regions zero cases. • Multidrug therapy (MD